New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
10:27 EDTTKMR, NNVC, BCRX, HEBMapp drug used to treat Ebola patients, CNN reports
A drug made by privately held Mapp Biopharmaceutical was used to treat the two Americans who contracted Ebola, CNN reports, citing a source familiar with details of the treatment. The experimental treatment called ZMapp had never been tried before in a human but had showed promise with monkeys, CNN adds. Shares of Tekmira (TKMR), NanoViricides (NNVC), BioCryst (BCRX) and Hemispherx (HEB) are moving higher in early trading after two Americans were flown home with Ebola. Reference Link
News For TKMR;NNVC;BCRX;HEB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 27, 2014
18:05 EDTTKMR, BCRXNYC boy with Ebola-like symptoms tests negative for disease, WSJ says
Subscribe for More Information
11:24 EDTTKMR, BCRXNovavax rises after announcing Ebola vaccine development program
Subscribe for More Information
07:27 EDTTKMR, BCRXYoung NYC boy tested for Ebola, NY Post reports
Subscribe for More Information
07:01 EDTNNVCNanoViricides signs CRADA with USAMRIID for anti-Ebola drug candidates
NanoViricides announced that it has executed a Collaborative Research and Development Agreement for Material Transfer with the U.S. Army Medical Research Institute of Infectious Diseases. Certain novel anti-Ebola nanomedicine drug candidates recently developed by the company will be evaluated by USAMRIID scientists in their BSL-4 facilities for activity against the Ebola virus under this agreement.
October 26, 2014
14:40 EDTTKMR, BCRXFDA issues Emergency Use Authorization for Ebola diagnostic tests
Subscribe for More Information
October 24, 2014
10:55 EDTTKMR, BCRXDallas nurse now Ebola virus free, to be released, NBC reports
NBC and other media outlets cites NIH on Nina Pham's release. Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED). Reference Link
October 23, 2014
15:25 EDTTKMR, BCRXNew York confirms health care worker being tested for Ebola
Subscribe for More Information
14:58 EDTBCRX, TKMRNew York doctor rushed to hospital with Ebola-like symptoms, NY Post reports
Subscribe for More Information
06:22 EDTTKMR, BCRXEU to boost Ebola research with EUR 24.4M
The European Commission has today announced EUR 24.4M from the EU budget for urgently needed Ebola research. The funding will go to five projects, ranging from a large-scale clinical trial of a potential vaccine, to testing existing and novel compounds to treat Ebola. The money from Horizon 2020, the EU research and innovation program, will be provided via a fast-track procedure in order to start work as soon as possible. The Commission is also working with industry on the further development of vaccines, drugs and diagnostics for Ebola and other haemorrhagic diseases within the Innovative Medicines Initiative. The funding will be provided following proposals from teams across the EU and in numerous 3rd countries, which were evaluated by an independent group of experts. The Commission has also asked the European and Developing Countries Clinical Trials Partnership to include emerging epidemics of concern to Africa, including Ebola, in its work plan. This will allow to fund clinical trials on drugs, vaccines and diagnostics in upcoming calls. Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED).
October 22, 2014
06:41 EDTBCRX, TKMRWHO fast-tracking testing of two Ebola vaccines, Guardian reports
Subscribe for More Information
October 21, 2014
19:53 EDTTKMRTekmira commences limited GMP manufacture of Ebola drug
Tekmira Pharmaceuticals provided an update on its Ebola program. The company is reporting it has commenced limited GMP manufacture of a new therapeutic specifically targeting the Ebola, Guinea variant, which is the viral variant responsible for the Ebola epidemic currently prevalent in West Africa. Supply of this new product will be available in early December, for potential use by various collaborators. The Company has completed the design of a modified RNAi therapeutic specifically targeting the Ebola viral variant, now termed 'Ebola-Guinea.' The company's IND for TKM-Ebola remains on partial clinical hold with respect to the multiple ascending dosing in healthy subjects. The company expects this matter to be resolved this quarter.
09:48 EDTTKMRShire could target BioMarin, TheStreet's Feuerstein says
Subscribe for More Information
07:21 EDTTKMRiBio valuation will be hard to maintain, TheStreet's Feuerstein says
iBio's current valuation will be hard to maintain "even under the best Ebola stockpiling scenario," TheStreet's Adam Feuerstein argues. He notes Ebola related stocks fell yesterday after the quarantines related to Thomas Duncan ended. Reference Link
October 20, 2014
12:02 EDTHEBHemispherx, Squire Patton Boggs partner to fight Ebola virus
Subscribe for More Information
09:09 EDTTKMR, BCRXEMA encourages applications for orphan designation for Ebola treatments
The European Medicines Agency encourages developers of treatments or vaccines against Ebola to apply for orphan designation. Applications for orphan designation of Ebola medicines will be treated as a priority and EMA has committed to fast-tracking their evaluation, the regulator announced. Drug companies that are working on experimental Ebola vaccines and treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX), NewLink Genetics (NLNK) and GlaxoSmithKline (GSK).
08:34 EDTHEBHemispherx prevails in federal lawsuit, seeks $1M award for fees, cost
Subscribe for More Information
October 19, 2014
16:44 EDTBCRX, TKMREbola drug discovery efforts intensify, WSJ says
Subscribe for More Information
13:39 EDTTKMR, BCRXCarnival cruise passenger tests negative for Ebola, Reuters says
Subscribe for More Information
October 17, 2014
14:50 EDTTKMR, BCRXBARDA asks labs to ramp up Zmapp production, Reuters says
Subscribe for More Information
09:46 EDTTKMR, BCRXSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use